These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

157 related items for PubMed ID: 10800762

  • 1. Sequential administration of arginine and arginine plus GHRH to test somatotroph function in short children.
    Bellone J, Aimaretti G, Bellone S, Baffoni C, Corneli G, Origlia C, Cappa M, Ghigo E.
    J Endocrinol Invest; 2000 Feb; 23(2):97-101. PubMed ID: 10800762
    [Abstract] [Full Text] [Related]

  • 2. Relationship between the morphological evaluation of the pituitary and the growth hormone (GH) response to GH-releasing hormone Plus arginine in children and adults with congenital hypopituitarism.
    Maghnie M, Salati B, Bianchi S, Rallo M, Tinelli C, Autelli M, Aimaretti G, Ghigo E.
    J Clin Endocrinol Metab; 2001 Apr; 86(4):1574-9. PubMed ID: 11297586
    [Abstract] [Full Text] [Related]

  • 3. Reproducibility of the growth hormone response to stimulation with growth hormone-releasing hormone plus arginine during lifespan.
    Valetto MR, Bellone J, Baffoni C, Savio P, Aimaretti G, Gianotti L, Arvat E, Camanni F, Ghigo E.
    Eur J Endocrinol; 1996 Nov; 135(5):568-72. PubMed ID: 8980159
    [Abstract] [Full Text] [Related]

  • 4. Reduction of the pituitary GH releasable pool in short children with GH neurosecretory dysfunction.
    Aimaretti G, Bellone S, Bellone J, Chiabotto P, Baffoni C, Corneli G, Origlia C, de Sanctis C, Camanni F, Ghigo E.
    Clin Endocrinol (Oxf); 2000 Mar; 52(3):287-93. PubMed ID: 10718826
    [Abstract] [Full Text] [Related]

  • 5. Arginine counteracts the inhibitory effect of recombinant human insulin-like growth factor I on the somatotroph responsiveness to growth hormone-releasing hormone in humans.
    Gianotti L, Maccario M, Lanfranco F, Ramunni J, Di Vito L, Grottoli S, Muller EE, Ghigo E, Arvat E.
    J Clin Endocrinol Metab; 2000 Oct; 85(10):3604-8. PubMed ID: 11061509
    [Abstract] [Full Text] [Related]

  • 6. Retesting young adults with childhood-onset growth hormone (GH) deficiency with GH-releasing-hormone-plus-arginine test.
    Aimaretti G, Baffoni C, Bellone S, Di Vito L, Corneli G, Arvat E, Benso L, Camanni F, Ghigo E.
    J Clin Endocrinol Metab; 2000 Oct; 85(10):3693-9. PubMed ID: 11061526
    [Abstract] [Full Text] [Related]

  • 7. Comparisons among old and new provocative tests of GH secretion in 178 normal adults.
    Aimaretti G, Baffoni C, DiVito L, Bellone S, Grottoli S, Maccario M, Arvat E, Camanni F, Ghigo E.
    Eur J Endocrinol; 2000 Apr; 142(4):347-52. PubMed ID: 10754475
    [Abstract] [Full Text] [Related]

  • 8. Patients with dilated cardiomyopathy show reduction of the somatotroph responsiveness to GHRH both alone and combined with arginine.
    Broglio F, Benso A, Gottero C, Vito LD, Aimaretti G, Fubini A, Arvat E, Bobbio M, Ghigo E.
    Eur J Endocrinol; 2000 Feb; 142(2):157-63. PubMed ID: 10664524
    [Abstract] [Full Text] [Related]

  • 9. Effect of withdrawal of somatostatin plus GH-releasing hormone as a stimulus of GH secretion in obesity.
    Alvarez P, Isidro L, Leal-Cerro A, Casanueva FF, Dieguez C, Cordido F.
    Clin Endocrinol (Oxf); 2002 Apr; 56(4):487-92. PubMed ID: 11966741
    [Abstract] [Full Text] [Related]

  • 10. Hexarelin, a synthetic GH-releasing peptide, is a powerful stimulus of GH secretion in pubertal children and in adults but not in prepubertal children and in elderly subjects.
    Bellone J, Bartolotta E, Sgattoni C, Aimaretti G, Arvat E, Bellone S, Deghenghi R, Ghigo E.
    J Endocrinol Invest; 1998 Sep; 21(8):494-500. PubMed ID: 9801989
    [Abstract] [Full Text] [Related]

  • 11. GHRH plus arginine in the diagnosis of acquired GH deficiency of childhood-onset.
    Maghnie M, Cavigioli F, Tinelli C, Autelli M, Aricò M, Aimaretti G, Ghigo E.
    J Clin Endocrinol Metab; 2002 Jun; 87(6):2740-4. PubMed ID: 12050243
    [Abstract] [Full Text] [Related]

  • 12. Short children with familial short stature show enhancement of somatotroph secretion but normal IGF-I levels.
    Bellone S, Corneli G, Bellone J, Baffoni C, Rovere S, de Sanctis C, Bona G, Ghigo E, Aimaretti G.
    J Endocrinol Invest; 2002 May; 25(5):426-30. PubMed ID: 12035938
    [Abstract] [Full Text] [Related]

  • 13. Assessment of GH/IGF-I axis in obesity by evaluation of IGF-I levels and the GH response to GHRH+arginine test.
    Maccario M, Gauna C, Procopio M, Di Vito L, Rossetto R, Oleandri SE, Grottoli S, Ganzaroli C, Aimaretti G, Ghigo E.
    J Endocrinol Invest; 1999 Jun; 22(6):424-9. PubMed ID: 10435851
    [Abstract] [Full Text] [Related]

  • 14. Comparison between insulin-induced hypoglycemia and growth hormone (GH)-releasing hormone + arginine as provocative tests for the diagnosis of GH deficiency in adults.
    Aimaretti G, Corneli G, Razzore P, Bellone S, Baffoni C, Arvat E, Camanni F, Ghigo E.
    J Clin Endocrinol Metab; 1998 May; 83(5):1615-8. PubMed ID: 9589665
    [Abstract] [Full Text] [Related]

  • 15. GH/IGF-I axis in Prader-Willi syndrome: evaluation of IGF-I levels and of the somatotroph responsiveness to various provocative stimuli. Genetic Obesity Study Group of Italian Society of Pediatric Endocrinology and Diabetology.
    Corrias A, Bellone J, Beccaria L, Bosio L, Trifirò G, Livieri C, Ragusa L, Salvatoni A, Andreo M, Ciampalini P, Tonini G, Crinò A.
    J Endocrinol Invest; 2000 Feb; 23(2):84-9. PubMed ID: 10800760
    [Abstract] [Full Text] [Related]

  • 16. Administration of arginine plus growth hormone releasing hormone to evaluate growth hormone (GH) secretory status in children with GH deficiency.
    Keller A, Donaubauer J, Kratzsch J, Pfaeffle R, Hirsch W, Kiess W, Keller E.
    J Pediatr Endocrinol Metab; 2007 Dec; 20(12):1307-14. PubMed ID: 18341090
    [Abstract] [Full Text] [Related]

  • 17. Low dose hexarelin and growth hormone (GH)-releasing hormone as a diagnostic tool for the diagnosis of GH deficiency in adults: comparison with insulin-induced hypoglycemia test.
    Gasperi M, Aimaretti G, Scarcello G, Corneli G, Cosci C, Arvat E, Martino E, Ghigo E.
    J Clin Endocrinol Metab; 1999 Aug; 84(8):2633-7. PubMed ID: 10443652
    [Abstract] [Full Text] [Related]

  • 18. Growth hormone (GH) responses to GH-releasing hormone alone or combined with arginine in patients with adrenal incidentaloma: evidence for enhanced somatostatinergic tone.
    Terzolo M, Bossoni S, Alí A, Doga M, Reimondo G, Milani G, Peretti P, Manelli F, Angeli A, Giustina A.
    J Clin Endocrinol Metab; 2000 Mar; 85(3):1310-5. PubMed ID: 10720081
    [Abstract] [Full Text] [Related]

  • 19. Hexarelin-induced growth hormone response in short stature. Comparison with growth hormone-releasing hormone plus pyridostigmine and arginine plus estrogen.
    Guzzaloni G, Grugni G, Morabito F.
    J Endocrinol Invest; 1999 May; 22(5):360-8. PubMed ID: 10401710
    [Abstract] [Full Text] [Related]

  • 20. The negative GH auto-feedback in childhood: effects of rhGH and/or GHRH on the somatotroph response to GHRH or hexarelin, a peptidyl GH secretagogue, in children.
    Bellone J, Bellone S, Aimaretti G, Valetto MR, Baffoni C, Corneli G, Origlia C, Arvat E, Ghigo E.
    J Endocrinol Invest; 2000 Mar; 23(3):158-62. PubMed ID: 10803472
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.